Sujata Sawhney
Overview
Explore the profile of Sujata Sawhney including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
589
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sadun R, Cooper J, Belot A, Avcin T, Aggarwal A, Ainsworth J, et al.
Ann Rheum Dis
. 2025 Feb;
84(2):158-168.
PMID: 39919891
Objectives: Childhood-onset systemic lupus erythematosus (cSLE), representing 15%-20% of individuals with SLE, has been difficult to study globally due to differences between registries. This initiative, supported by Childhood Arthritis Rheumatology...
2.
Sawhney S
Indian J Pediatr
. 2023 Dec;
91(10):1056-1064.
PMID: 38100070
Of the primary vasculitis pediatricians are familiar with, Kawasaki disease and IgA vasculitis are the most common. The other large, medium and small vessel vasculitis are seldom seen in practice....
3.
Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Terreri M, Sakamoto A, et al.
J Scleroderma Relat Disord
. 2023 Jun;
8(2):120-130.
PMID: 37287945
Objective: To compare organ involvement and disease severity between male and female patients with juvenile onset systemic sclerosis. Methods: Demographics, organ involvement, laboratory evaluation, patient-reported outcomes and physician assessment variables...
4.
Scott C, Sawhney S, Lewandowski L
Rheum Dis Clin North Am
. 2021 Nov;
48(1):199-215.
PMID: 34798947
Pediatric rheumatology subspecialists treat chronic autoimmune diseases with onset in childhood. Prompt diagnosis and ongoing management of these conditions are imperative to prevent damage from ongoing inflammation. Here, we aim...
5.
van Straalen J, Krol R, Giancane G, Panaviene V, Ailioaie L, Dolezalova P, et al.
Rheumatology (Oxford)
. 2021 Sep;
61(5):2104-2112.
PMID: 34508559
Objective: To describe risk factors for IBD development in a cohort of children with JIA. Methods: JIA patients who developed IBD were identified from the international Pharmachild register. Characteristics were...
6.
Sawhney S, Agarwal M
Lupus
. 2021 Jul;
30(11):1829-1836.
PMID: 34315295
Children with systemic lupus erythematosus have a more challenging and difficult course as compared to their adult counterparts. Today, the aim of therapy for any child with lupus is to...
7.
Foeldvari I, Klotsche J, Kasapcopur O, Adrovic A, Terreri M, Sakamoto A, et al.
Arthritis Care Res (Hoboken)
. 2021 Mar;
74(10):1575-1584.
PMID: 33787070
Objective: To evaluate the baseline clinical characteristics of juvenile systemic sclerosis (SSc) patients in the international juvenile SSc inception cohort, and to compare these characteristics between the classically defined juvenile...
8.
Foeldvari I, Klotsche J, Hinrichs B, Helmus N, Kasapcopur O, Adrovic A, et al.
Arthritis Care Res (Hoboken)
. 2020 Nov;
74(3):364-370.
PMID: 33141441
Objective: Utilizing data obtained from a prospective, international, juvenile systemic sclerosis (SSc) cohort, the present study was undertaken to determine if pulmonary screening with forced vital capacity (FVC) and diffusing...
9.
Tibaldi J, Pistorio A, Aldera E, Puzone L, Miedany Y, Pal P, et al.
Rheumatology (Oxford)
. 2020 Aug;
59(11):3505-3514.
PMID: 32829413
Objective: To develop a composite disease activity score for systemic JIA (sJIA) and to provide preliminary evidence of its validity. Methods: The systemic Juvenile Arthritis Disease Activity Score (sJADAS) was...
10.
Agrawal H, Doan H, Pham B, Khosla A, Babu M, McCluskey P, et al.
Indian J Ophthalmol
. 2020 Aug;
68(9):1852-1862.
PMID: 32823402
There are multiple approaches to inhibit inflammatory molecules and pathways in noninfectious uveitis. The cornerstone of local and systemic anti-inflammatory treatment is corticosteroid therapy. Corticosteroids remain the most potent and...